ProPhase Labs, Inc. (PRPH): History, Ownership, Mission, How It Works & Makes Money

Ever heard of ProPhase Labs, Inc. (PRPH) and wondered what they're all about? This next-generation biotech, genomics, and consumer products company has been making headlines, especially with its strategic restructuring and focus on innovative healthcare solutions. With a recent sale of its Pharmaloz manufacturing operations for $23 million in January 2025 and a significant reduction in employee headcount, is ProPhase Labs poised for a turnaround? Keep reading to explore the history, ownership, mission, operational structure, and revenue streams of this intriguing company.

ProPhase Labs, Inc. (PRPH) History

ProPhase Labs, Inc. Founding Timeline

Year established

ProPhase Labs, Inc. was established in 1999.

Original location

The company's original location was in Garden City, NY.

Founding team members

The key people involved in founding the company included:

• Michael Biordi
• Theodore ('Ted') Karkus

Initial capital/funding

Information regarding the initial capital and funding for ProPhase Labs' establishment is not readily available in the provided search results.

ProPhase Labs, Inc. Evolution Milestones

ProPhase Labs, Inc. Transformative Moments

ProPhase Labs has undergone several transformative moments that have shaped its evolution:

• Strategic Acquisitions: The acquisitions of Pharmaloz Manufacturing and Cold-EEZE® were pivotal in expanding the company's manufacturing capabilities and product range in the OTC market.
• Diagnostic Services Expansion: The establishment of ProPhase Diagnostics and the subsequent launch of COVID-19 testing services during the pandemic marked a significant shift towards diagnostic testing, driving substantial revenue and market presence. In 2021, diagnostic services revenue reached $126.3 million.
• Entry into Genomics: The acquisition of Nebula Genomics in 2021 signaled a strategic move into the high-growth area of consumer genomics, aligning the company with personalized health and preventative medicine trends.
• Leadership Changes: The transition in leadership, particularly with Ted Karkus taking on roles such as CEO, has been instrumental in steering the company through various strategic pivots and growth phases.

These moments reflect ProPhase Labs' strategic agility and its ability to capitalize on emerging market opportunities, transitioning from a traditional manufacturing base to a diversified healthcare and diagnostics company. To gain more insight into the company's guiding principles, explore Mission Statement, Vision, & Core Values of ProPhase Labs, Inc. (PRPH).

ProPhase Labs, Inc. (PRPH) Ownership Structure

ProPhase Labs, Inc. features a mix of individual and institutional ownership, influencing its strategic direction and corporate governance.

ProPhase Labs, Inc.'s Current Status

ProPhase Labs, Inc. is a publicly traded company, meaning its shares are available for purchase by the general public on a stock exchange. As of December 31, 2024, ProPhase Labs had a market capitalization of approximately $24.58 million.

ProPhase Labs, Inc.'s Ownership Breakdown

Understanding the ownership structure of ProPhase Labs provides insights into who has influence over the company's decisions. The following table summarizes the ownership breakdown:

ProPhase Labs, Inc.'s Leadership

The leadership team is responsible for the day-to-day operations and strategic direction of ProPhase Labs. Key members include:

• Curt Billings: President, Chief Executive Officer, and Director
• Dana Banks: Chief Financial Officer
• Theodore (Ted) Karkus: Founder and Chairman of the Board

For more insights into the company's goals and values, visit Mission Statement, Vision, & Core Values of ProPhase Labs, Inc. (PRPH).

ProPhase Labs, Inc. (PRPH) Mission and Values

ProPhase Labs aims to improve health and wellness through diagnostics and genomics testing. Its core values emphasize innovation, accuracy, and customer satisfaction.

ProPhase Labs' Core Purpose

Official mission statement

While an official, stand-alone mission statement for ProPhase Labs isn't readily available, their activities and public statements suggest a mission focused on:

• Advancing healthcare through innovative diagnostic and genomic solutions.
• Providing accessible and accurate testing services to improve patient outcomes.
• Delivering value to shareholders through strategic growth and operational excellence.

Vision statement

Similarly, a specific vision statement isn't formally published. However, based on their strategic direction, a potential vision for ProPhase Labs could be:

• To be a leading provider of diagnostic and genomic testing services, recognized for innovation, accuracy, and customer satisfaction.
• To expand access to advanced healthcare solutions, empowering individuals and healthcare providers to make informed decisions.
• To drive sustainable growth and create long-term value for stakeholders.

Company slogan/tagline

ProPhase Labs does not have a widely publicized official slogan or tagline. Instead, they emphasize their services and capabilities through descriptive language. You can explore more about ProPhase Labs' financial standing and investment potential at: Breaking Down ProPhase Labs, Inc. (PRPH) Financial Health: Key Insights for Investors

ProPhase Labs, Inc. (PRPH) How It Works

ProPhase Labs, Inc. operates as a multifaceted company focusing on diagnostics, genomics, and marketing, leveraging its CLIA-certified laboratories and direct-to-consumer marketing strategies to deliver health-related services and products.

ProPhase Labs, Inc.'s Product/Service Portfolio

ProPhase Labs, Inc.'s Operational Framework

ProPhase Labs, Inc. integrates its laboratory services with direct-to-consumer marketing and strategic partnerships to deliver value. Here’s a breakdown:

• Laboratory Operations: Operates CLIA-certified laboratories equipped for high-volume sample processing and advanced diagnostic testing.
• Direct-to-Consumer Marketing: Employs digital marketing and partnerships to reach consumers directly, offering convenient access to testing services.
• Strategic Partnerships: Collaborates with healthcare providers, institutions, and other organizations to expand service reach and market penetration.

More information can be found here: Mission Statement, Vision, & Core Values of ProPhase Labs, Inc. (PRPH).

ProPhase Labs, Inc.'s Strategic Advantages

ProPhase Labs, Inc. maintains a competitive edge through several key factors:

• CLIA-Certified Labs: Ensures high-quality, reliable testing services.
• Scalable Infrastructure: Ability to handle large volumes of tests, crucial during peak demand periods like pandemics.
• Direct-to-Consumer Model: Allows for greater control over the customer experience and data collection.
• Diverse Service Portfolio: Offers a range of diagnostic and genomic services, reducing reliance on a single product or market.

ProPhase Labs, Inc. (PRPH) How It Makes Money

ProPhase Labs, Inc. primarily generates revenue through the sale of diagnostic testing services and, to a lesser extent, through the distribution of its own line of dietary supplements and personal care products.

ProPhase Labs, Inc. Revenue Breakdown

As ProPhase Labs' business evolves, revenue streams are subject to change. For the most up-to-date information, refer to the company's latest financial reports.

ProPhase Labs, Inc. Business Economics

ProPhase Labs, Inc.'s business economics are influenced by several factors, including the demand for diagnostic testing, the pricing of their services, and the cost of goods sold for their products.

• Diagnostic Testing Services: Revenue in this segment depends on test volumes, reimbursement rates from insurance companies and government programs, and the cost of testing supplies and labor.
• Dietary Supplements and Personal Care Products: This revenue stream is affected by production costs, marketing expenses, and the pricing strategy employed to compete with other brands.

ProPhase Labs, Inc. Financial Performance

Analyzing ProPhase Labs, Inc.’s financial performance involves looking at key indicators that reflect the company's overall health and profitability.

• Revenue: Total revenue indicates the overall sales generated from diagnostic testing services and the sale of dietary supplements and personal care products.
• Gross Profit Margin: The gross profit margin reflects the efficiency of ProPhase Labs in managing its production costs.
• Operating Expenses: Monitoring operating expenses, including research and development, sales and marketing, and administrative costs, is crucial to assess the company's cost management.
• Net Income: Net income provides a comprehensive view of overall profitability, taking into account all revenues and expenses.
• Cash Flow: Analyzing cash flow from operations, investing, and financing activities helps to understand the company's liquidity and financial stability.

To gain more insights into the company, check this out: Exploring ProPhase Labs, Inc. (PRPH) Investor Profile: Who’s Buying and Why?

ProPhase Labs, Inc. (PRPH) Market Position & Future Outlook

ProPhase Labs is strategically positioned to leverage its diversified business segments, including diagnostic services and genomics, to capitalize on evolving healthcare needs. The company's future outlook is shaped by its ability to innovate in diagnostics, expand its market reach, and navigate the competitive landscape effectively.

Competitive Landscape

Opportunities & Challenges

Industry Position

ProPhase Labs holds a notable position within the diagnostic and genomics industry, characterized by:

• Diversified Service Portfolio: Offering a range of diagnostic testing services and genomics solutions, allowing it to cater to various healthcare needs.
• Focus on Innovation: Actively pursuing innovative diagnostic solutions and technologies to stay competitive.
• Strategic Growth Initiatives: Engaging in strategic acquisitions to expand its market presence and enhance its service offerings.

To gain more insights into the company's values and long-term goals, check out Mission Statement, Vision, & Core Values of ProPhase Labs, Inc. (PRPH).